Department of Cardiology, Mercy University Hospital, Grenville Place, Cork, Ireland.
Ir J Med Sci. 2011 Dec;180(4):819-22. doi: 10.1007/s11845-011-0726-0. Epub 2011 Jun 25.
Warfarin is used for the treatment of thromboembolic disease. It requires careful and sustained monitoring due to its narrow therapeutic index and potentially life-threatening complications. Patient education and knowledge is, therefore, vital.
To assess, in a specialised anticoagulation clinic, the extent of patients' knowledge of their warfarin treatment.
Ethical approval was obtained. All patients, aged over 18 years, attending our anticoagulation clinic during our study period were asked to participate.
We enrolled 181 patients, 47.9% of respondents were unaware of any potential drug interactions, 57.7% of patients were unaware of any potential side effects, 20% of patients had experienced side effects, 10.9% of patients had been hospitalised due to side effects, 58% of which were due to Haemorrhage and 79% of patients kept a personal record of their INR.
Patients' understanding of warfarin treatment was poor, despite their high level of compliance.
华法林用于治疗血栓栓塞性疾病。由于其治疗指数较窄且可能危及生命，因此需要仔细和持续的监测。因此，患者教育和知识至关重要。
在专门的抗凝诊所评估患者对其华法林治疗的了解程度。
获得伦理批准。在我们的研究期间，所有年龄在 18 岁以上、在我们的抗凝诊所就诊的患者都被要求参与。
我们招募了 181 名患者，47.9%的受访者不知道任何潜在的药物相互作用，57.7%的患者不知道任何潜在的副作用，20%的患者经历过副作用，10.9%的患者因副作用住院，其中 58%是由于出血，79%的患者保留了他们的 INR 个人记录。
尽管患者的依从性很高，但他们对华法林治疗的理解很差。
